drugset / Trial / NCT01377779

Efficiency of Intercoat (Oxiplex/AP Gel)in Decreasing Intrauterine Adhesions

NCT01377779 ↗

Completed 60 enrolled Assaf-Harofeh Medical Center
RandomizedSingle-groupSingle-blindPrevention

Summary

This is a prospective single blind randomized controlled pilot study was designed to investigate whether the biological barrier Intercoat (Oxiplex/AP gel) reduces formation of intrauterine adhesions following hysteroscopic treatment for retained products of conception.

Timeline

Start
2009-09
Primary completion
2010-11
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxiplex/AP gel Unknown — Other

Indications